A Multimodal iPSC Platform for Cystic Fibrosis Drug Testing

Scientists generated a panel of airway epithelial cells using iPSCs from individuals with common or rare cystic fibrosis transmembrane conductance regulator (CFTR) variants representative of three distinct classes of CFTR dysfunction.